Melinta Therapeutics (MLNTQ) Short Interest Ratio & Short Volume → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free MLNTQ Stock Alerts $0.11 0.00 (0.00%) (As of 04/20/2020) Add Compare Share Share Short InterestStock Analysis Melinta Therapeutics Short Interest DataCurrent Short Volume1,173,200 sharesPrevious Short Volume958,200 sharesChange Vs. Previous Month+22.44%Dollar Volume Sold Short$99,839.32Short Interest Ratio / Days to Cover9.8Last Record DateApril 15, 2020Today's Trading Volume32,900 sharesAverage Trading Volume0 sharesToday's Volume Vs. Average∞ Short Selling Melinta Therapeutics ? Sign up to receive the latest short interest report for Melinta Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMLNTQ Short Interest Over TimeMLNTQ Days to Cover Over TimeMLNTQ Percentage of Float Shorted Over Time Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. Melinta Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20201,173,200 shares $99,839.32 +22.4%N/A9.8 $0.09 3/31/2020958,200 shares $0.00 -8.9%N/A5.8 $0.00 3/13/20201,051,300 shares $105,130.00 -20.8%N/A3.4 $0.10 2/28/20201,326,500 shares $92,855.00 -8.5%N/A8.2 $0.07 2/14/20201,450,400 shares $188,552.00 -5.9%N/A6.9 $0.13 1/31/20201,541,100 shares $0.00 -21.2%N/A5 $0.00 1/15/20201,956,300 shares $0.00 No ChangeN/A2.7 $0.00 MLNTQ Short Interest - Frequently Asked Questions What is Melinta Therapeutics' current short interest? Short interest is the volume of Melinta Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 1,173,200 shares of MLNTQ short. Learn More on Melinta Therapeutics' current short interest. What is a good short interest ratio for Melinta Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MLNTQ shares currently have a short interest ratio of 10.0. Learn More on Melinta Therapeutics's short interest ratio. Is Melinta Therapeutics' short interest increasing or decreasing? Melinta Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 1,173,200 shares, an increase of 22.4% from the previous total of 958,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Melinta Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Melinta Therapeutics: Context Therapeutics Inc. (0.29%), LAVA Therapeutics (1.37%), Mainz Biomed (2.30%), NLS Pharmaceutics Ltd. (0.34%), and Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AbbVie Inc. ($6.93 billion), Charter Communications, Inc. ($4.47 billion), Tesla, Inc. ($2.93 billion), Match Group, Inc. ($2.71 billion), The Charles Schwab Co. ($2.47 billion), Microchip Technology Incorporated ($2.38 billion), The Clorox Company ($2.03 billion), Aurora Cannabis Inc. ($1.85 billion), Wayfair Inc. ($1.84 billion), and PDD Holdings Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Melinta Therapeutics stock? Short selling MLNTQ is an investing strategy that aims to generate trading profit from Melinta Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Melinta Therapeutics? A short squeeze for Melinta Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MLNTQ, which in turn drives the price of the stock up even further. How often is Melinta Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MLNTQ, twice per month. The most recent reporting period available is April, 15 2020. More Short Interest Resources from MarketBeat Related Companies: Abliva AB (publ) Short Squeeze Affymax Short Squeeze American Bio Medica Short Squeeze Anthera Pharmaceuticals Short Squeeze Bayer Aktiengesellschaft Short Squeeze Context Therapeutics Short Squeeze EOM Pharmaceuticals Short Squeeze EPIRUS Biopharmaceuticals Short Squeeze GlobeImmune Short Squeeze International Stem Cell Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:MLNTQ) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”Altimetry